000			02134 a2200685 4500
005			20250517065222.0
264		0	_c20160919
008			201609s 0 0 eng d
022			_a1665-2681
024	7		_a10.5604/16652681.1184212 _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, David D
245	0	0	_aEarly allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. _h[electronic resource]
260			_bAnnals of hepatology _c
300			_a53-60 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlanine Transaminase _xblood
650	0	4	_aAllografts
650	0	4	_aAspartate Aminotransferases _xblood
650	0	4	_aBilirubin _xblood
650	0	4	_aBiomarkers _xblood
650	0	4	_aChi-Square Distribution
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aClinical Enzyme Tests
650	0	4	_aFemale
650	0	4	_aFlorida _xepidemiology
650	0	4	_aGraft Survival
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInternational Normalized Ratio
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLength of Stay
650	0	4	_aLiver Transplantation _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrimary Graft Dysfunction _xblood
650	0	4	_aProportional Hazards Models
650	0	4	_aQuality Improvement
650	0	4	_aQuality Indicators, Health Care
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aCroome, Kristopher P
700	1		_aShalev, Jefree A
700	1		_aMusto, Kaitlyn R
700	1		_aSharma, Meenu
700	1		_aKeaveny, Andrew P
700	1		_aTaner, C Burcin
773	0		_tAnnals of hepatology _gvol. 15 _gno. 1 _gp. 53-60
856	4	0	_uhttps://doi.org/10.5604/16652681.1184212 _zAvailable from publisher's website
999			_c25504480 _d25504480